Evidence map›Paper›PMID 28472961›Full record

ArticleCardiovascular diabetology2017

Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.

Marcus Wiemer, Sinisa Stojkovic, Alexander Samol, Zisis Dimitriadis, Juan M Ruiz-Nodar, Ralf Birkemeyer, Jacques Monsegu, Gérard Finet, David Hildick-Smith, Damras Tresukosol and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiovascular diabetology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Snapshot on Clinical Trials on Zotarolimus DES: A Repurposing Drug against Myocardial Infarction.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Marcus WiemerDepartment of Cardiology and Intensive Care Medicine, Johannes Wesling University Hospital, Ruhr University Bochum, Hans-Nolte-Str. 1, 32429, Minden, Germany. marcus.wiemer@muehlenkreiskliniken.de.
Sinisa StojkovicClinic for Cardiology, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
Alexander SamolDepartment of Cardiology and Intensive Care Medicine, Johannes Wesling University Hospital, Ruhr University Bochum, Hans-Nolte-Str. 1, 32429, Minden, Germany.
Zisis DimitriadisDepartment of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
Juan M Ruiz-NodarHospital General Universitario de Alicante, Universidad Miguel Hernández, Alicante, Spain.
Ralf BirkemeyerHerzklinik Ulm, Ulm, Germany.
Jacques MonseguGroupe Hospitalier Mutualiste de Grenoble, Grenoble, France.
Gérard FinetHospital Cardiovasculaire Louis Pradel, Bron, France.
David Hildick-SmithSussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK.
Damras TresukosolSiriraj Hospital, Bangkok, Thailand.
Enrique Garcia NovoHospital Guadalajara, Guadalajara, Spain.
Jacques J Koolen, St. Catharina Eindhoven, Eindhoven, The Netherlands.
Emanuele BarbatoCardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium.
Gian Battista DanziOspedale Santa Corona, Pietra Ligure, Italy.
NOBORI 2 investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28472961
PMCPMC5418688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.